Literature DB >> 11465834

Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease.

P Coplan1, S Black, C Rojas, H Shinefield, P Ray, E Lewis, H Guess.   

Abstract

BACKGROUND: A 15-year postmarketing evaluation of the impact of varicella vaccine on the age distribution of varicella disease is being conducted at Kaiser Permanente Medical Care Program, Northern California (KPMCP). We report on a baseline assessment of the age-specific incidence and hospitalization rates of varicella and herpes zoster that was conducted before vaccine introduction.
METHODS: To assess the annual incidence of varicella, a telephone survey was conducted in a random sample of approximately 8,000 youths 5 to 19 years of age. The annual incidence of hospitalizations for varicella and herpes zoster in 1994 was assessed with the use of the computerized database at KPMCP.
RESULTS: Varicella annual incidence was 10.3% in 5- to 9-year-olds, 1.9% in 10- to 14-year-olds and 1.2% in the 15- to 19-year age groups, respectively. Hospitalization rates among the entire KPMCP membership were 2.6 and 2.1 per 100,000 person years for varicella and zoster, respectively. Varicella incidence in the 15- to 19-year age group was higher among African-Americans than among Caucasians.
CONCLUSIONS: Varicella rates were similar in the 5- to 9- and 10- to 14-year age groups to rates from other published studies conducted in 1972 to 1978, 1980 to 1988 and 1990 to 1992; however, the rate in 15- to 19-year-olds was 2 to 4 times higher than published rates in the same age category.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465834     DOI: 10.1097/00006454-200107000-00002

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  Presumptive varicella vaccination is warranted in Greek adolescents lacking a history of disease or household exposure.

Authors:  Alexandra Katsafadou; Konstantina Kallergi; George Ferentinos; Theodora Goulioti; Maria Foustoukou; Vassiliki Papaevangelou
Journal:  Eur J Pediatr       Date:  2008-04-05       Impact factor: 3.183

2.  A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China.

Authors:  Li Lu; Luodan Suo; Juan Li; Xinghuo Pang
Journal:  Hum Vaccin Immunother       Date:  2018-07-30       Impact factor: 3.452

3.  Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans.

Authors:  Ralph P Insinga; Robbin F Itzler; James M Pellissier
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  Increased risk of herpes zoster in children with asthma: a population-based case-control study.

Authors:  Bong-Seong Kim; Sonia Mehra; Barbara Yawn; Charles Grose; Robert Tarrell; Brian Lahr; Young J Juhn
Journal:  J Pediatr       Date:  2013-04-13       Impact factor: 4.406

5.  Compliance with herpes zoster vaccination in young and adult individuals in two regions of Italy.

Authors:  Antonino Parlato; Vincenzo Romano Spica; Massimo Ciccozzi; Francesca Farchi; Francesca Gallè; Valeria Di Onofrio; Elisabetta Franco; Giorgio Liguori
Journal:  BMC Public Health       Date:  2010-06-12       Impact factor: 3.295

6.  Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella.

Authors:  Samir S Shah; Sarah M Wood; Xiquan Luan; Adam J Ratner
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

7.  The epidemiology of varicella in school-aged Greek children before the implementation of universal vaccination.

Authors:  A Katsafadou; G Ferentinos; A Constantopoulos; V Papaevangelou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-16       Impact factor: 3.267

8.  The burden of severe varicella in Spain, 1995--2000 period.

Authors:  Angel Gil; Antonio González; Itziar Oyagüez; María San Martín; Pilar Carrasco
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 9.  Systematic review of incidence and complications of herpes zoster: towards a global perspective.

Authors:  Kosuke Kawai; Berhanu G Gebremeskel; Camilo J Acosta
Journal:  BMJ Open       Date:  2014-06-10       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.